Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06503536
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-10
Brief Title:
A Study to Assess Treatment Patterns Clinical Outcomes and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis AD Through Chart Review
Sponsor:
None
Organization:
None
Study Overview
Official Title:
REAL-world Patient characterISTICs Treatment Pattern Clinical Outcomes and Healthcare Resource Utilization in Chinese Patients Receiving Upadacitinib for Atopic Dermatitis A Retrospective Chart Review Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Atopic Dermatitis AD is a common chronic and flaring systemic inflammatory skin disorder characterized by intensely pruritic and distressing skin eruptions This study will assess treatment patterns treatment outcomes healthcare resource utilization in Chinese participants receiving Upadacitinib for Atopic Dermatitis AD undergoing chart review
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None